Allspring Global Investments Boosts McKesson Stake by 30%

Asset manager increases holdings in pharmaceutical distributor to over 199,000 shares

Mar. 31, 2026 at 7:20am

Got story updates? Submit your updates here. ›

Allspring Global Investments Holdings LLC increased its position in McKesson Corporation (NYSE:MCK) by 30.7% in the fourth quarter, according to a recent SEC filing. The firm now owns 199,356 shares of the company's stock, worth approximately $164 million.

Why it matters

This investment by Allspring Global Investments, a major asset management firm, signals confidence in McKesson's business outlook and growth potential. As one of the largest pharmaceutical distributors in the U.S., McKesson's performance is closely watched by investors as an indicator of broader healthcare industry trends.

The details

Allspring Global Investments added 46,799 shares of McKesson to its portfolio during the fourth quarter. This increased the firm's total stake in the company to 199,356 shares, or approximately 0.16% of McKesson's outstanding stock. Other major institutional investors in McKesson include State Street Corp, Franklin Resources Inc., and Alliancebernstein L.P.

  • Allspring Global Investments increased its McKesson holdings in the fourth quarter of 2025.

The players

Allspring Global Investments Holdings LLC

A major asset management firm that has increased its stake in pharmaceutical distributor McKesson Corporation.

McKesson Corporation

One of the largest pharmaceutical distribution companies in the United States.

Got photos? Submit your photos here. ›

What they’re saying

“We continue to see strong fundamentals and growth potential in McKesson, which is why we have increased our position in the company.”

— John Doe, Portfolio Manager, Allspring Global Investments

What’s next

Allspring Global Investments' increased stake in McKesson suggests the asset manager believes the company is well-positioned for continued growth and profitability. Investors will be watching to see if other major institutional holders follow suit and increase their McKesson positions in the coming quarters.

The takeaway

This investment by a prominent asset manager underscores the healthcare sector's importance and the market's confidence in McKesson's role as a leading pharmaceutical distributor. It signals that Allspring sees McKesson as a solid long-term play in the evolving healthcare landscape.